| Date Filed | Type | Description |
| 03/07/2023 |
4
| Ben Yong (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 5,307 options to buy
@ $2.85, valued at
$15.1k
|
|
| 03/07/2023 |
3
| Ben Yong (Director) has filed a Form 3 on Corbus Pharmaceuticals Holdings, Inc. |
| 09/28/2022 |
4
| Altmeyer Anne (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 159,200 options to buy
@ $0.16, valued at
$25.5k
|
|
| 09/28/2022 |
3
| Altmeyer Anne (Director) has filed a Form 3 on Corbus Pharmaceuticals Holdings, Inc. |
| 08/12/2022 |
4
| Millian Craig Stuart (COO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Bought 5,000 shares
@ $0.2545, valued at
$1.3k
|
|
| 08/11/2022 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Bought 3,800 shares
@ $0.264, valued at
$1k
|
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Salzmann Peter (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 79,600 options to buy
@ $0.33, valued at
$26.3k
|
|
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Bought 10,500 shares
@ $0.25, valued at
$2.6k
|
|
| 03/11/2022 |
4
| Millian Craig Stuart (COO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Bought 10,000 shares
@ $0.37, valued at
$3.7k
|
|
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Bought 8,600 shares
@ $0.37, valued at
$3.2k
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 1,489,700 options to buy
@ $0.47, valued at
$700.2k
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2021 |
4
| Brake Rachael Louise (Chief Scientific Officer) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 500,000 options to buy
@ $0.7474, valued at
$373.7k
|
|
| 12/08/2021 |
3
| Brake Rachael Louise (Chief Scientific Officer) has filed a Form 3 on Corbus Pharmaceuticals Holdings, Inc. |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 58,200 options to buy
@ $2.07, valued at
$120.5k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 956,500 options to buy
@ $2.58, valued at
$2.5M
|
|
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| White Barbara (Chief Medical Officer) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 307,300 options to buy
@ $2.58, valued at
$792.8k
|
|
| 12/22/2020 |
4
| Moran Sean F. (CFO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Sold 53,610 shares
@ $1.4, valued at
$75.1k
Sold 87,500 shares
@ $1.75, valued at
$153.1k
Exercised 53,610 options to buy
@ $1, valued at
$53.6k
Exercised 87,500 options to buy
@ $1.4, valued at
$122.5k
|
|
| 12/18/2020 |
4
| Moran Sean F. (CFO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Sold 36,923 shares
@ $1.317, valued at
$48.6k
Exercised 36,923 options to buy
@ $0.1657, valued at
$6.1k
|
|
|